Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin

被引：123

作者：

Chan, Pan F. ^{[1
]}

Srikannathasan, Velupillai ^{[2
]}

Huang, Jianzhong ^{[1
]}

Cui, Haifeng ^{[1
]}

Fosberry, Andrew P. ^{[2
]}

Gu, Minghua ^{[1
]}

Hann, Michael M. ^{[2
]}

Hibbs, Martin ^{[2
]}

Homes, Paul ^{[2
]}

Ingraham, Karen ^{[1
]}

Pizzollo, Jason ^{[1
]}

Shen, Carol ^{[1
]}

Shillings, Anthony J. ^{[2
]}

Spitzfaden, Claus E. ^{[2
]}

Tanner, Robert ^{[2
]}

Theobald, Andrew J. ^{[2
]}

Stavenger, Robert A. ^{[1
]}

Bax, Benjamin D. ^{[2
]}

Gwynn, Michael N. ^{[1
]}

机构：

[1] GlaxoSmithKline, Antibacterial Discovery Performance Unit, Infect Dis, Therapy Area Unit, Collegeville, PA 19426 USA

[2] GlaxoSmithKline, Platform Technol & Sci, Med Res Ctr, Stevenage SG1 2NY, Herts, England

来源：

NATURE COMMUNICATIONS | 2015年 / 6卷

基金：

英国惠康基金;

关键词：

IN-VITRO ACTIVITY; TOPOISOMERASE-IV; QUINOLONE RESISTANCE; II TOPOISOMERASES; MECHANISM; AZD0914; REFINEMENT; COMPLEXES; MUTATION; SENSITIVITY;

D O I：

10.1038/ncomms10048

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

New antibacterials are needed to tackle antibiotic-resistant bacteria. Type IIA topoisomerases (topo2As), the targets of fluoroquinolones, regulate DNA topology by creating transient double-strand DNA breaks. Here we report the first co-crystal structures of the antibacterial QPT-1 and the anticancer drug etoposide with Staphylococcus aureus DNA gyrase, showing binding at the same sites in the cleaved DNA as the fluoroquinolone moxifloxacin. Unlike moxifloxacin, QPT-1 and etoposide interact with conserved GyrB TOPRIM residues rationalizing why QPT-1 can overcome fluoroquinolone resistance. Our data show etoposide's antibacterial activity is due to DNA gyrase inhibition and suggests other anticancer agents act similarly. Analysis of multiple DNA gyrase co-crystal structures, including asymmetric cleavage complexes, led to a 'pair of swing-doors' hypothesis in which the movement of one DNA segment regulates cleavage and religation of the second DNA duplex. This mechanism can explain QPT-1's bacterial specificity. Structure-based strategies for developing topo2A antibacterials are suggested.

引用

页数：13

共 61 条

[31] High In Vitro Activity of the Novel Spiropyrimidinetrione AZD0914, a DNA Gyrase Inhibitor, against Multidrug-Resistant Neisseria gonorrhoeae Isolates Suggests a New Effective Option for Oral Treatment of Gonorrhea [J].

Jacobsson, Susanne ;

Golparian, Daniel ;

Alm, Richard A. ;

Huband, Michael ;

Mueller, John ;

Jensen, Jorgen Skov ;

Ohnishi, Makoto ;

Unemo, Magnus .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) :5585-5588

[32] Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914 [J].

Kern, Gunther ;

Palmer, Tiffany ;

Ehmann, David E. ;

Shapiro, Adam B. ;

Andrews, Beth ;

Basarab, Gregory S. ;

Doig, Peter ;

Fan, Jun ;

Gao, Ning ;

Mills, Scott D. ;

Mueller, John ;

Sriram, Shubha ;

Thresher, Jason ;

Walkup, Grant K. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (34) :20984-20994

[33] In Vitro Activity of AZD0914, a Novel DNA Gyrase Inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae [J].

Kohlhoff, Stephan A. ;

Huband, Michael D. ;

Hammerschlag, Margaret R. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (12) :7595-7596

[34] Inference of macromolecular assemblies from crystalline state [J].

Krissinel, Evgeny ;

Henrick, Kim .

JOURNAL OF MOLECULAR BIOLOGY, 2007, 372 (03) :774-797

[35] Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases [J].

Laponogov, Ivan ;

Pan, Xiao-Su ;

Veselkov, Dennis A. ;

McAuley, Katherine E. ;

Fisher, L. Mark ;

Sanderson, Mark R. .

PLOS ONE, 2010, 5 (06)

[36] Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerases [J].

Liu, QY ;

Wang, JC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :881-886

[37] Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases [J].

Miles, Timothy J. ;

Hennessy, Alan J. ;

Bax, Ben ;

Brooks, Gerald ;

Brown, Barry S. ;

Brown, Pamela ;

Cailleau, Nathalie ;

Chen, Dongzhao ;

Dabbs, Steven ;

Davies, David T. ;

Esken, Joel M. ;

Giordano, Ilaria ;

Hoover, Jennifer L. ;

Huang, Jianzhong ;

Jones, Graham E. ;

Sukmar, Senthill K. Kusalakumari ;

Spitzfaden, Claus ;

Markwell, Roger E. ;

Minthorn, Elisabeth A. ;

Rittenhouse, Steve ;

Gwynn, Michael N. ;

Pearson, Neil D. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (19) :5437-5441

[38] Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors [J].

Miller, Alita A. ;

Bundy, Gordon L. ;

Mott, John E. ;

Skepner, Jill E. ;

Boyle, Timothy P. ;

Harris, Douglas W. ;

Hromockyj, Alexander E. ;

Marotti, Keith R. ;

Zurenko, Gary E. ;

Munzner, Jennifer B. ;

Sweeney, Michael T. ;

Bammert, Gary F. ;

Hamel, Judith C. ;

Ford, Charles W. ;

Zhong, Wei-Zhu ;

Graber, David R. ;

Martin, Gary E. ;

Han, Fusen ;

Dolak, Lester A. ;

Seest, Eric P. ;

Ruble, J. Craig ;

Kamilar, Gregg M. ;

Palmer, John R. ;

Banitt, Lee S. ;

Hurd, Alexander R. ;

Barbachyn, Michael R. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (08) :2806-2812

[39] REPLICATION AND REPAIR OF DNA IN CELLS OF ESCHERICHIA-COLI TREATED WITH TOLUENE [J].

MOSES, RE ;

RICHARDSON, CC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1970, 67 (02) :674-+

[40] REFMAC5 for the refinement of macromolecular crystal structures [J].

Murshudov, Garib N. ;

Skubak, Pavol ;

Lebedev, Andrey A. ;

Pannu, Navraj S. ;

Steiner, Roberto A. ;

Nicholls, Robert A. ;

Winn, Martyn D. ;

Long, Fei ;

Vagin, Alexei A. .

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2011, 67 :355-367

← 1 2 3 4 5 6 7 →